Reports from ShenYang Medical College Advance Knowledge in Nanoparticles (Superior Doxorubicin Cellular Delivery Effect Established By Optically Active Mesoporous Silica Nanoparticles).
In: Clinical Oncology Week, 2024-03-26, S. 859-859
serialPeriodical
Zugriff:
A report from ShenYang Medical College in Liaoning, China, discusses the use of optically active mesoporous silica nanoparticles for drug delivery in cancer cells. The researchers studied two types of nanoparticles, LOA-MSNs and DOA-MSNs, and found that they did not exhibit cytotoxicity in cancer cells. The study also showed that DOA-MSNs had a stronger cytotoxic effect due to their higher retention and accumulation in cells. The researchers concluded that DOA-MSNs have the potential to advance the development of optical anti-tumor delivery systems. This research has been peer-reviewed and published in Drug Delivery and Translational Research. [Extracted from the article]
Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Reports from ShenYang Medical College Advance Knowledge in Nanoparticles (Superior Doxorubicin Cellular Delivery Effect Established By Optically Active Mesoporous Silica Nanoparticles).
|
---|---|
Zeitschrift: | Clinical Oncology Week, 2024-03-26, S. 859-859 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6799 (print) |
Schlagwort: |
|
Sonstiges: |
|